share_log

NanoVibronix Signs Agreement For Research And Development Of Next Generation PainShield And UroShield

NanoVibronix Signs Agreement For Research And Development Of Next Generation PainShield And UroShield

NanoVibronix 簽署下一代 PainShield 和 UroShield 的研發協議
Benzinga ·  03/28 08:36

Efforts Focused on Adding Therapeutic Functionality and Reducing Costs

工作重點是增加治療功能和降低成本

NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield, PainShield and WoundShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an agreement with Veranex, Inc. ("Veranex") to assist with the development of the company's next generation UroShield and PainShield products.

生產UroShield、PainShield和WoundShield表面聲波（SAW）便攜式超聲波治療設備的醫療器械公司NanoVibronix, Inc.（納斯達克股票代碼：NAOV）（“NanoVibronix” 或 “公司”）今天宣佈，它已與Veranex, Inc.（“Veranex”）簽訂協議，協助開發該公司的下一代UroShield和PainShield產品。

Under the terms of the agreement, Veranex will provide certain research and development services as related to PainShield and UroShield.

根據協議條款，Veranex將提供與PainShield和UroShield相關的某些研發服務。

Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, "Teaming up with Veranex provides us with access to additional industry expertise and manufacturing know-how to further improve our products and stay ahead of the innovation curve. By working with an outside partner with proven methods and techniques to evolve our products, we believe we will be able to offer a next generation of products that not only increases clinician and patient satisfaction but also future-proofs the components and reduces our cost of goods."

NanoVibronix, Inc. 首席執行官布萊恩·墨菲表示：“與Veranex合作使我們能夠獲得更多的行業專業知識和製造知識，從而進一步改進我們的產品並保持創新領先地位。通過與擁有成熟方法和技術的外部合作伙伴合作來改進我們的產品，我們相信我們將能夠提供下一代產品，這些產品不僅可以提高臨床醫生和患者的滿意度，還可以使組件經得起未來考驗並降低我們的商品成本。”

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論